Vanguard Group Inc Guardant Health, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,701,945 shares of GH stock, worth $363 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,701,945
Previous 11,636,732
0.56%
Holding current value
$363 Million
Previous $336 Million
20.16%
% of portfolio
0.0%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding GH
# of Institutions
323Shares Held
127MCall Options Held
844KPut Options Held
2.38M-
Black Rock Inc. New York, NY11.2MShares$349 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$314 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$215 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$186 Million5.07% of portfolio
-
Baillie Gifford & CO5.87MShares$182 Million0.1% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.17B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...